MediPharm Labs’ Board Continues Value Destruction for Shareholders with Sale of Hope Facility

MediPharm Labs' Board Continues Value Destruction for Shareholders with Sale of Hope Facility

“It’s a travesty for shareholders to have what is believed to be a $12M asset sold for just $4.5M, likely netting shareholders less than $4M after fees and expenses. Worse still, the acquirer will wisely use the facility to produce cannabis for export that will directly compete with MediPharm in Europe,” says Regan McGee of Apollo Capital.

MediPharm Labs’ Board Continues Value Destruction for Shareholders with Sale of Hope Facility

Complete Incompetence at the Board Level Results in Fire Sale of Treasured MediPharm Asset, the Hope Facility, to a Competitor Hope Facility was One...